A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis

Clinical trial NCT05250115 · TERMINATED

Trial details

NCT number: NCT05250115
Sponsor: Pfizer
Status: TERMINATED
Study type: OBSERVATIONAL

Dermatitis, Atopic

Start date: 2022-05-10
Primary completion: 2024-07-25
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.